Puyod, Agripino B.

HRN: 27-22-65  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/06/2025
06/10/2025
IVT
500mg
Q24H
CAP-HR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: